Body temperature, motor activity, and feeding behavior of mice treated with beta-chlornaltrexamine.
The effects of an irreversible long term opioid antagonism on circadian rhythms in body temperature (Tb), locomotor activity (Act) and feeding under normal conditions and following lipopolysaccharide administration (LPS; 2.5 mg/kg) have been investigated in unrestrained mice housed at their thermoneutral zone (30 degrees C). beta-chlornaltrexamine (beta-CNA; 5 mg/kg) given intraperitoneally decreased Tb on the day of injection, depressed Act, and reduced food and water intake for several days. The drug destroyed circadian rhythm in Tb for 4 consecutive days after administration due to prevention of the night time increases in temperature, whereas mean day time Tb of mice treated with beta-CNA remained similar to controls. Between days 5-8 the day-time Tb of beta-CNA-injected mice decreased, and the mice started displaying regular daily variations albeit with smaller amplitude and at lower level than controls. The depressive effect of beta-CNA on circadian variation in activity was more prolonged than its effect on Tb suggesting that these two variables are independently regulated. beta-CNA prevented the febrile response of the mice to LPS and enhanced the hypophagic effect of LPS. We conclude that normal circadian rhythms in Tb and Act, as well as certain symptoms of sickness behavior, have an opioid component.
Kozak
W
W
Institute for Basic and Applied Medical Research, Lovelace Institutes, Albuquerque, NM 87108, USA.
Conn
C A
CA
Kluger
M J
MJ
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D002940:Circadian Rhythm / Q000187:drug effects; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects*; D004926:Escherichia coli; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D013686:Telemetry
D008070:Lipopolysaccharides; D009292:Narcotic Antagonists; D009271:Naltrexone; C017120:chlornaltrexamine